Tag: CINA-ASPECTS
Viz.ai announces integration of Avicenna.AI’s CINA-ASPECTS stroke severity assessment tool
Leading artificial intelligence (AI)-based medical imaging companies Viz.ai and Avicenna.AI have announced the integration of Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into Viz.ai’s One platform....
Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools
Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products.
CINA-ASPECTS is...
